In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents.

The in vitro activity of Bay v 3522, a new aminobenzothiazol cephem, was compared with those of other oral beta-lactams. Bay v 3522 displayed high activity against Staphylococcus spp. (MICs for 90% of strains tested [MIC90S], 0.5 micrograms/ml), Streptococcus pneumoniae (MIC90, 0.06 micrograms/ml),...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Wise, R, Andrews, J M, Ashby, J P, Thornber, D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171697/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2360820/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.5.813
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!